The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Losses in HDFC and ICICI Bank contributed the most to Sensex decline
Alkem Laboratories was up 10% at Rs 1,517 while Dr Lal PathLabs up 8% to Rs 893 on the BSE at 03:11 p.m.
The stock surged 10% to Rs 437 after the company bagged export order from Siam Kubota Corp.
Schrader Duncan, ARSS Infrastructure and Kemrock Industries too locked in upper circuit of 20% on the BSE.
It launched high speed 4G mobile phone services across South India on Wednesday, ahead of the Reliance Jio
Pipavav Defence, Bharat Electronics, Walchandnagar Ind and Astra Microwave Products were up 4%-18% on BSE.
Gains in auto shares contributed the most to Sensex gains along with pharma shares
Tree House dipped 5% at Rs 196, while Zee Learn down 3% to Rs 39.75, falling nearly 10% from intra-day high of Rs 44 on the BSE.
The early indicator SGX Nifty is trading 0.3% higher at 7,889 levels
The stock rallied 6% to Rs 510 as the company introduced of an advanced novel therapy CIMIVIR-L for the treatment of Hepatitis C in India.
The stock rallied 17% to Rs 574 after the RBI approved hike in investment limit by overseas investors by up to 49%.
The stock ended 32% higher at Rs 1,382 after hitting a high of Rs 1,414 on the NSE
The stock ended 50% higher at Rs 825 on the NSE after hitting a high of Rs 844
Energy and metal shares were the top gainers
Bajaj Finance, Berger Paints, Indraprastha Gas, Tata Elxsi, Jet Airways and Trent from BSE A-group hit 52-week high.
Shree Pushkar Chem, Manpasand Beverages, PNC Infra, Navkar Corp and Prabhat Dairy that had listed at par or below their issue price are currently quoting at a huge premium.
Markets are trading higher in line with the global peers following a modest recovery in the oil prices
The company has secured 7 product patents across SE Asia and Europe
The company said it has reached an amicable settlement with FCCB (Series B) bond holders
Reliance Industries contributed the most to the benchmark indices along with Sun Pharma